Filing Details
- Accession Number:
- 0001127602-14-006368
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-02-14 13:24:47
- Reporting Period:
- 2014-02-12
- Filing Date:
- 2014-02-14
- Accepted Time:
- 2014-02-14 13:24:47
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
799729 | Parexel International Corp | PRXL | Services-Commercial Physical & Biological Research (8731) | 042776269 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1278042 | A Mark Goldberg | Parexel International Corporation 195 West Street Waltham MA 02451 | President & Coo | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2014-02-12 | 12,072 | $30.18 | 117,160 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2014-02-12 | 127 | $12.55 | 117,287 | No | 4 | M | Direct | |
Common Stock | Disposition | 2014-02-12 | 12,199 | $50.49 | 105,088 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-02-12 | 12,072 | $0.00 | 12,072 | $30.18 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2014-02-12 | 127 | $0.00 | 127 | $12.55 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
37,928 | 2016-09-11 | No | 4 | M | Direct | |
0 | 2017-09-09 | No | 4 | M | Direct |
Footnotes
- The reported sale was effected by a broker pursuant to instructions set forth in a Rule 10b5-1 trading plan adopted by the reporting person.
- Currently exercisable.